Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks
NASDAQ:HSCS

HeartSciences 7/19/2023 Earnings Report

HeartSciences logo
$3.51 +0.12 (+3.54%)
Closing price 03:59 PM Eastern
Extended Trading
$3.51 0.00 (-0.03%)
As of 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
ProfileEarnings HistoryForecast

HeartSciences EPS Results

Actual EPS
-$16.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

HeartSciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

HeartSciences Announcement Details

Quarter
Date
7/19/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

HeartSciences' next earnings date is estimated for Thursday, September 11, 2025, based on past reporting schedules.

Conference Call Resources

HeartSciences Earnings Headlines

HeartSciences (HSCS) Expected to Announce Earnings on Monday
August 3, 2025  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30252625
HeartSciences Inc.: HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
July 25, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-07/65998572-heartsciences-inc-heartsciences-provides-business-update-and-reports-fiscal-2025-financial-results-399.htm
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
August 13 at 2:00 AM  |  InvestorPlace (Ad)
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
July 24, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/24/3121466/0/en/heartsciences-provides-business-update-and-reports-fiscal-2025-financial-results.html
HeartSciences amends bylaws to add jury trial waiver and ownership threshold - Investing.com
July 3, 2025  |  investing.comhttps://www.investing.com/news/sec-filings/heartsciences-amends-bylaws-to-add-jury-trial-waiver-and-ownership-threshold-93CH-4120181
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
June 4, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/04/3093617/0/en/heartsciences-receives-fda-breakthrough-device-designation-for-myovista-insights-ai-ecg-algorithm-for-detecting-aortic-stenosis.html
See More HeartSciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like HeartSciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on HeartSciences and other key companies, straight to your email.

About HeartSciences

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

View HeartSciences Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles